About The Study: From 2015 to 2023, the number of U.S. patients who were prescribed long-term opioid therapy declined, potentially owing to national opioid stewardship efforts and growing awareness of the risks. However, approximately 4 million to 5 million patients were prescribed long-term opioid therapy in 2023, depending on the definition used. Moreover, there were demographic shifts in the patients prescribed long-term opioid therapy over this period in that patients were older and the largest proportion now had opioid therapy covered by Medicare. Because older adults are at higher risk of adverse events from polypharmacy, the increased rates of coprescribing, particularly with gabapentinoids, raises additional safety concerns.
Corresponding Author: To contact the corresponding author, Thuy D. Nguyen, PhD, email thuydn@umich.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2026.3241)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.3241?guestAccessKey=1615432b-8638-49eb-9608-b3b11a1ab7b7&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040826
JAMA